We're here for you if you want to talk

0808 2080 888

[email protected]


Our £500 million investment into research since 1960 has helped transform treatments and taken us to the point where beating blood cancer is now in sight. Our researchers are working to finish the job.

Close-up of Covid-19 vaccine vials laid out in rows.

Research blogs

Learn more about our blood cancer research and for regular updates on what we know about the effectiveness of covid vaccines for people with blood cancer.

A close up of someone's hands with blue gloves on - they are squeezing a syringe into a vile.

The coronavirus vaccine: what you need to know

We explain what we know about the potential vaccines and what they could mean for people with blood cancer.

Hugo, who was diagnosed with childhood acute lymphoblastic leukaemia, posing at home with a large helium balloon.

Why we fund Research

We want to ensure the 40,000 people diagnosed with blood cancer in the UK each year are given effective treatments. Find out more about how research discoveries can change the lives of people with blood cancer.

Our research impact

Over the last 60 years we have invested an incredible £500 million into blood cancer research. This has led to a long line of breakthroughs that have improved treatments and saved lives.

Find out more

The graphic reads "We are currently funding 82 different blood cancer research projects, across 27 institutions across the UK. That's around 145 researchers"

The projects you help us fund

Right now, we’re funding leading blood cancer researchers across the UK and we’ll keep going until the day where we can beat all blood cancers.

The VIVO Biobank

VIVO Biobank is a cutting-edge facility which collects, stores, and processes samples from children who have been given a diagnosis of cancer.

Find out more

Professor Chris Bunce stands in a red lab coat in a laboratory.

Funding for researchers

Our blood cancer research grants include long and short term projects, career development awards and basic research through to phase III clinical trials.

Image with the title "The Road to Beating Blood Cancer" and a dashed line indicating a road.

The road to beating blood cancer

This is how researchers, in the UK and abroad, think we'll beat blood cancer in a generation.

Researcher Professor Peter Hillmen who is funded by Blood Cancer UK talking with a colleague over a booklet of notes.

Our policy on open access

We believe that free access to and unrestricted re-use of published research is the best way to share and build upon new knowledge and ideas.

A composite photo consisting of 12 headshots of members of Blood Cancer UK's Research Strategy Patient Panel.

Our Research Strategy Patient Panel

Our Research Strategy Patient Panel are currently playing a vital role in helping us to set our research priorities, so that we can continue to have the biggest impact possible.

Icon of a medical syringe in Blood Cancer UK branding of red and purple.

The Blood Cancer UK Vaccine Task Force

Understanding the response to COVID-19 vaccination

A close up of a person in a laboratory coat holding a multichannel pipette.

Research strategy

We're a community dedicated to beating blood cancer. We do this by funding research and supporting those affected.